Background Symptoms of post-acute sequelae of COVID-19 (PASC) may improve following
SARS-CoV-2 vaccination. However few prospective data that also explore the underlying …

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that have
mutations associated with increased transmission and antibody escape have arisen over the …

SARS-CoV-2 vaccination has proven effective in inducing an immune response in healthy
individuals and is progressively us allowing to overcome the pandemic. Recent evidence …

The advent of COVID-19 vaccines will play a major role in helping to end the pandemic that
has killed millions worldwide. Vaccine candidates have demonstrated robust humoral …

Background: BNT162b2 and mRNA-1273 are the two recently approved mRNA-based
vaccines against COVID-19 which has shown excellent safety and efficacy. Preliminary data …

Understanding vaccine-mediated protection against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 …

In this review, we address issues that relate to the rapid “Warp Speed” development of
vaccines to counter the COVID-19 pandemic. We review the antibody response that is …

Although mRNA vaccines encoding the spike protein of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) prevent COVID-19, the emergence of new viral variants …

Abstract mRNA-based vaccines dramatically reduce the occurrence and severity of COVID-
19, but are associated with rare vaccine-related adverse effects. These toxicities, coupled …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of a
global pandemic. Safe and effective COVID-19 vaccines are now available, including mRNA …